This page is archived, and being kept only for reference, research, or record-keeping purposes and is no longer updated.

If this page is inaccessible to you, please complete this form to request it be made accessible. Please do not use this form to report issues related to the content of this page or for general queries. All other questions or problems please seek assistance at my.umbc.edu/help.

UMBC a Model for STEM | UMBC Industry News

With over 300 graduates currently pursuing graduate and professional degrees in STEM fields, UMBC is recognized as a leader in STEM education. In today’s Industry Roundup, we take a look at how Chan Zuckerberg is using UMBC’s Meyerhoff Model and investing $6.9M to diversify STEM. We also look at the new management of health data using Alexa, a new AI rollout for health professionals, and generic drug competitors.

Industry Roundup is brought to you by UMBC’s Division of Professional Studies, offering a broad array of professionally-focused master’s degree and certificate programs that address industry needs while anticipating future opportunities.


UMBC’s successful STEM program is Serving as a Model

UMBC’s successful STEM honors program has caught the attention of Facebook’s founder Mark Zuckerberg and his wife, Dr. Priscilla Chan. Impressed by UMBC’s success within STEM, this successful business duo announced that they will fund an effort to bring similar STEM success to two University of California colleges.


How Alexa is Managing Your Health Info

Guess who is now HIPAA eligible? It was only a matter of time before Amazon’s Alexa built up the skills to handle sensitive data related to your healthcare. Find out which of the top healthcare organizations will launch Alexa’s Skills Kit.


New AI Rollout to Healthcare Professionals

A new #AI toolbox for clinicians and researchers in the #healthcare industry will soon be available via Boston-based Partners Healthcare.


Let the Generic Drug Competition Begin

Competition is a good thing. It keeps us on our toes. It creates a catalyst to growth and development. It can bring out the very best in us. Will this be the case with the new US FDA draft guidance for generic competition?

Leave a comment

Your email address will not be published. Required fields are marked *